Behavioral Changes : Many patients report changes in their eating behaviors, such as improved portion control and a preference for healthier food options, when using GLP-1 therapies
S., Klein, R
However, neither drug affected liver fibrosis in these groups
Different dose ranges are being tested in studies, with 12 mg weekly as the maximum dose tested so far
Garca-Cceres C, Quarta C, Varela L, Gao Y, Gruber T, Legutko B, et al
In many cases, digestive symptoms are temporary and improve as the body adapts, but persistent or severe symptoms should always be discussed with your healthcare provider. Everyone Responds Differently Some participants reported very few side effects, while others experienced more noticeable gastrointestinal symptoms